Beneficial effects of resveratrol on respiratory chain defects in patients' fibroblasts involve estrogen receptor and estrogen-related receptor alpha signaling

Human Molecular Genetics

Volumn 23, Issue 8, 2014, Pages 2106-2119

  Lopes costa, Alexandra ^a   Le bachelier, Carole ^a   Mathieu, Lise ^a   Rotig, Agnès ^b   Boneh, Avihu ^c   De lonlay, Pascale ^b,d   Tarnopolsky, Mark A ^e   Thorburn, David R ^c   Bastin, Jean ^a,f   Djouadi, Fatima ^a,f  

^a INSERM   (France)

^b IMAGINE INSTITUTE   (France)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

^e MCMASTER UNIVERSITY   (Canada)

^f ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE KINASE; ESTROGEN RECEPTOR; ESTROGEN RELATED RECEPTOR ALPHA; LACTIC ACID; RESVERATROL; SIRTUIN 1;

ARTICLE; CELL STIMULATION; CELL TYPE; COMPLEX I DEFICIENCY; CONTROLLED STUDY; CYTOCHROME C OXIDASE DEFICIENCY; DRUG EFFECT; ENZYME ACTIVITY; FIBROBLAST; HUMAN; HUMAN CELL; MITOCHONDRIAL RESPIRATION; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; RESPIRATORY CHAIN; SIGNAL TRANSDUCTION; UPREGULATION;

ANTICARCINOGENIC AGENTS; BLOTTING, WESTERN; CELLS, CULTURED; CYTOCHROME-C OXIDASE DEFICIENCY; ELECTRON TRANSPORT; ELECTRON TRANSPORT COMPLEX I; ELECTRON TRANSPORT COMPLEX IV; ESTROGEN RECEPTOR ALPHA; FIBROBLASTS; HUMANS; LACTATES; MITOCHONDRIAL MEMBRANES; OXYGEN CONSUMPTION; PYRUVATES; RECEPTORS, ESTROGEN; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SIRTUIN 1; SKIN; STILBENES;

EID: 84897878074     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddt603     Document Type: Article

References (54)

1. Koopman, W.J., Willems, P.H. and Smeitink, J.A. (2012) Monogenic mitochondrial disorders. N. Engl. J. Med., 366, 1132-1141.
2. Pfeffer, G., Majamaa, K., Turnbull, D.M., Thorburn, D. and Chinnery, P.F. (2012) Treatment for mitochondrial disorders. Cochrane Database Syst. Rev., 4, CD004426.
3. Stacpoole, P.W. (1989) The pharmacology of dichloroacetate. Metabolism, 38, 1124-1144.
4. Bastin, J., Aubey, F., Rotig, A., Munnich, A. and Djouadi, F. (2008) Activation of peroxisome proliferator-activated receptor pathway stimulates the mitochondrial respiratory chain and can correct deficiencies in patients' cells lacking its components. J. Clin. Endocrinol. Metab., 93, 1433-1441.
5. Wenz, T., Wang, X., Marini, M. and Moraes, C.T. (2011) A metabolic shift induced by a PPAR panagonist markedly reduces the effects of pathogenic mitochondrial tRNA mutations. J. Cell. Mol. Med., 15, 2317-2325.
6. Viscomi, C., Bottani, E., Civiletto, G., Cerutti, R., Moggio, M., Fagiolari, G., Schon, E.A., Lamperti, C. and Zeviani, M. (2011) In vivo correction of COX deficiency by activation of the AMPK/PGC-1alpha axis. Cell. Metab., 14, 80-90.
7. Wenz, T., Diaz, F., Spiegelman, B.M. and Moraes, C.T. (2008) Activation of the PPAR/PGC-1alpha pathway prevents a bioenergetic deficit and effectively improves a mitochondrial myopathy phenotype. Cell. Metab., 8, 249-256.
8. Scarpulla, R.C., Vega, R.B. and Kelly, D.P. (2012) Transcriptional integration of mitochondrial biogenesis. Trends Endocrinol. Metab., 23, 459-466.
9. Handschin, C. and Spiegelman, B.M. (2006) Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism. Endocr. Rev., 27, 728-735.
10. Fernandez-Marcos, P.J. and Auwerx, J. (2011) Regulation of PGC-1alpha, a nodal regulator of mitochondrial biogenesis. Am. J. Clin. Nutr., 93, 884-890.
11. Howitz, K.T., Bitterman, K.J., Cohen, H.Y., Lamming, D.W., Lavu, S., Wood, J.G., Zipkin, R.E., Chung, P., Kisielewski, A., Zhang, L.L. et al. (2003) Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature, 425, 191-196.
12. Park, S.J., Ahmad, F., Philp, A., Baar, K., Williams, T., Luo, H., Ke, H., Rehmann, H., Taussig, R., Brown, A.L. et al. (2012) Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell, 148, 421-433.
13. Price, N.L., Gomes, A.P., Ling, A.J., Duarte, F.V., Martin-Montalvo, A., North, B.J., Agarwal, B., Ye, L., Ramadori, G., Teodoro, J.S. et al. (2012) SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function. Cell. Metab., 15, 675-690.
14. Gehm, B.D., McAndrews, J.M., Chien, P.Y. and Jameson, J.L. (1997) Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc. Natl. Acad. Sci. U S A, 94, 14138-14143.
15. Chen, J.Q., Cammarata, P.R., Baines, C.P. and Yager, J.D. (2009) Regulation of mitochondrial respiratory chain biogenesis by estrogens/estrogen receptors and physiological, pathological and pharmacological implications. Biochim. Biophys. Acta, 1793, 1540-1570.
16. Eichner, L.J. and Giguere, V. (2011) Estrogen related receptors (ERRs): a new dawn in transcriptional control of mitochondrial gene networks. Mitochondrion, 11, 544-552.
17. Arain, S., Weiss, S., Heinzle, E., John, G.T., Krause, C. and Klimant, I. (2005) Gas sensing in microplates with optodes: influence of oxygen exchange between sample, air, and plate material. Biotechnol. Bioeng., 90, 271-280.
18. Deshpande, R.R., Koch-Kirsch, Y., Maas, R., John, G.T., Krause, C. and Heinzle, E. (2005) Microplates with integrated oxygen sensors for kinetic cell respiration measurement and cytotoxicity testing in primary and secondary cell lines. Assay Drug Dev. Technol., 3, 299-307.
19. Noor, F., Niklas, J., Muller-Vieira, U. and Heinzle, E. (2009) An integrated approach to improved toxicity prediction for the safety assessment during preclinical drug development using Hep G2 cells. Toxicol. Appl. Pharmacol., 237, 221-231.
20. Heller, A., Fischer, L.H., Wolfbeis, O.S. and Goepferich, A. (2012) Long time monitoring of the respiratory activity of isolated mitochondria. Exp. Cell. Res., 318, 1667-1672.
21. Robinson, B.H. (2006) Lactic acidemia and mitochondrial disease. Mol. Genet. Metab., 89, 3-13.
22. Kang, D., Kim, S.H. and Hamasaki, N. (2007) Mitochondrial transcription factor A (TFAM): roles in maintenance of mtDNA and cellular functions. Mitochondrion, 7, 39-44.
23. Baur, J.A., Pearson, K.J., Price, N.L., Jamieson, H.A., Lerin, C., Kalra, A., Prabhu, V.V., Allard, J.S., Lopez-Lluch, G., Lewis, K. et al. (2006) Resveratrol improves health and survival of mice on a high-calorie diet. Nature, 444, 337-342.
24. Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Messadeq, N., Milne, J., Lambert, P., Elliott, P. et al. (2006) Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell, 127, 1109-1122.
25. Csiszar, A., Labinskyy, N., Pinto, J.T., Ballabh, P., Zhang, H., Losonczy, G., Pearson, K., de Cabo, R., Pacher, P., Zhang, C. et al. (2009) Resveratrol induces mitochondrial biogenesis in endothelial cells. Am. J. Physiol. Heart Circ. Physiol., 297, H13-H20.
26. Denu, J.M. (2012) Fortifying the link between SIRT1, resveratrol, and mitochondrial function. Cell Metab., 15, 566-567.
27. Hou, X., Xu, S., Maitland-Toolan, K.A., Sato, K., Jiang, B., Ido, Y., Lan, F., Walsh, K., Wierzbicki, M., Verbeuren, T.J. et al. (2008) SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase. J. Biol. Chem., 283, 20015-20026.
28. Canto, C., Gerhart-Hines, Z., Feige, J.N., Lagouge, M., Noriega, L., Milne, J.C., Elliott, P.J., Puigserver, P. and Auwerx, J. (2009) AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature, 458, 1056-1060.
29. Bernier, M., Paul, R.K., Martin-Montalvo, A., Scheibye-Knudsen, M., Song, S., He, H.J., Armour, S.M., Hubbard, B.P., Bohr, V.A., Wang, L. et al. (2011) Negative regulation of STAT3 protein-mediated cellular respiration by SIRT1 protein. J. Biol. Chem., 286, 19270-19279.
30. Djouadi, F., Aubey, F., Schlemmer, D. and Bastin, J. (2005) Peroxisome proliferator activated receptor {delta} (PPAR{delta}) agonist but not PPAR{alpha} corrects carnitine palmitoyl transferase 2 deficiency in human muscle cells. J. Clin. Endocrinol. Metab., 90, 1791-1797.
31. Djouadi, F., Bonnefont, J.P., Thuillier, L., Droin, V., Khadom, N., Munnich, A. and Bastin, J. (2003) Correction of fatty acid oxidation in carnitine palmitoyl transferase 2-deficient cultured skin fibroblasts by bezafibrate. Pediatr. Res., 54, 446-451.
32. Menzies, K.J., Singh, K., Saleem, A. and Hood, D.A. (2013) Sirtuin 1-mediated effects of exercise and resveratrol on mitochondrial biogenesis. J. Biol. Chem., 288, 6968-6979.
33. Bowers, J.L., Tyulmenkov, V.V., Jernigan, S.C. and Klinge, C.M. (2000) Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta. Endocrinology, 141, 3657-3667.
34. Giordano, C., Montopoli, M., Perli, E., Orlandi, M., Fantin, M., Ross-Cisneros, F.N., Caparrotta, L., Martinuzzi, A., Ragazzi, E., Ghelli, A. et al. (2011) Oestrogens ameliorate mitochondrial dysfunction in Leber's hereditary optic neuropathy. Brain, 134, 220-234.
35. Richardson, T.E., Yu, A.E., Wen, Y., Yang, S.H. and Simpkins, J.W. (2012) Estrogen prevents oxidative damage to the mitochondria in Friedreich's ataxia skin fibroblasts. PLoS One, 7, e34600.
36. Robb, E.L. and Stuart, J.A. (2011) Resveratrol interacts with estrogen receptor-beta to inhibit cell replicative growth and enhance stress resistance by upregulating mitochondrial superoxide dismutase. Free Radic. Biol. Med., 50, 821-831.
37. Willy, P.J., Murray, I.R., Qian, J., Busch, B.B., Stevens, W.C. Jr., Martin, R., Mohan, R., Zhou, S., Ordentlich, P., Wei, P. et al. (2004) Regulation of PPARgamma coactivator 1alpha (PGC-1alpha) signaling by an estrogen-related receptor alpha (ERRalpha) ligand. Proc. Natl. Acad. Sci. U S A, 101, 8912-8917.
38. Mootha, V.K., Handschin, C., Arlow, D., Xie, X., St Pierre, J., Sihag, S., Yang, W., Altshuler, D., Puigserver, P., Patterson, N. et al. (2004) Erralpha and Gabpa/b specify PGC-1alpha-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle. Proc. Natl. Acad. Sci. U S A, 101, 6570-6575.
39. Suetsugi, M., Su, L., Karlsberg, K., Yuan, Y.C. and Chen, S. (2003) Flavone and isoflavone phytoestrogens are agonists of estrogen-related receptors. Mol. Cancer Res., 1, 981-991.
40. Liu, D., Zhang, Z., Gladwell, W. and Teng, C.T. (2003) Estrogen stimulates estrogen-related receptor alpha gene expression through conserved hormone response elements. Endocrinology, 144, 4894-4904.
41. Timmers, S., Konings, E., Bilet, L., Houtkooper, R.H., van de Weijer, T., Goossens, G.H., Hoeks, J., van der Krieken, S., Ryu, D., Kersten, S. et al. (2011) Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab., 14, 612-622.
42. Bastin, J., Lopes-Costa, A. and Djouadi, F. (2011) Exposure to resveratrol triggers pharmacological correction of fatty acid utilization in human fatty acid oxidation-deficient fibroblasts. Hum. Mol. Genet., 20, 2048-2057.
43. Passoneau, J.V. and Lowry, O.H. (1993) Enzymatic Analysis: A Practical Guide. The Humana Press, Inc., Totowa.
44. Barrientos, A. (2002) In vivo and in organello assessment of OXPHOS activities. Methods, 26, 307-316.
45. Benit, P., Chretien, D., Kadhom, N., de Lonlay-Debeney, P., Cormier-Daire, V., Cabral, A., Peudenier, S., Rustin, P., Munnich, A. and Rotig, A. (2001) Large-scale deletion and point mutations of the nuclear NDUFV1 and NDUFS1 genes in mitochondrial complex I deficiency. Am. J. Hum. Genet., 68, 1344-1352.
46. Calvo, S.E., Tucker, E.J., Compton, A.G., Kirby, D.M., Crawford, G., Burtt, N.P., Rivas, M., Guiducci, C., Bruno, D.L., Goldberger, O.A. et al. (2010) High-throughput, pooled sequencing identifies mutations in NUBPL and FOXRED1 in human complex I deficiency. Nat. Genet., 42, 851-858.
47. Worgan, L.C. (2005) The role of nuclear-encoded subunit genes in mitochondrial complex I deficiency. Thesis, Master of Science. Murdoch Institute Melbourne, School of Woman and Children's Health.
48. Benit, P., Beugnot, R., Chretien, D., Giurgea, I., De Lonlay-Debeney, P., Issartel, J.P., Corral-Debrinski, M., Kerscher, S., Rustin, P., Rotig, A. et al. (2003) Mutant NDUFV2 subunit of mitochondrial complex I causes early onset hypertrophic cardiomyopathy and encephalopathy. Hum. Mutat., 21, 582-586.
49. Benit, P., Slama, A., Cartault, F., Giurgea, I., Chretien, D., Lebon, S., Marsac, C., Munnich, A., Rotig, A. and Rustin, P. (2004) Mutant NDUFS3 subunit of mitochondrial complex I causes Leigh syndrome. J. Med. Genet., 41, 14-17.
50. Kirby, D.M., Salemi, R., Sugiana, C., Ohtake, A., Parry, L., Bell, K.M., Kirk, E.P., Boneh, A., Taylor, R.W., Dahl, H.H. et al. (2004) NDUFS6 mutations are a novel cause of lethal neonatal mitochondrial complex I deficiency. J. Clin. Invest., 114, 837-845.
51. Pagliarini, D.J., Calvo, S.E., Chang, B., Sheth, S.A., Vafai, S.B., Ong, S.E., Walford, G.A., Sugiana, C., Boneh, A., Chen, W.K. et al. (2008) A mitochondrial protein compendium elucidates complex I disease biology. Cell, 134, 112-123.
52. Valnot, I., von Kleist-Retzow, J.C., Barrientos, A., Gorbatyuk, M., Taanman, J.W., Mehaye, B., Rustin, P., Tzagoloff, A., Munnich, A. and Rotig, A. (2000) A mutation in the human heme A: farnesyltransferase gene (COX10) causes cytochrome c oxidase deficiency. Hum. Mol. Genet., 9, 1245-1249.
53. Tiranti, V., Hoertnagel, K., Carrozzo, R., Galimberti, C., Munaro, M., Granatiero, M., Zelante, L., Gasparini, P., Marzella, R., Rocchi, M. et al. (1998) Mutations of SURF-1 in Leigh disease associated with cytochrome c oxidase deficiency. Am. J. Hum. Genet., 63, 1609-1621.
54. Von Kleist-Retzow, J.C., Yao, J., Taanman, J.W., Chantrel, K., Chretien, D., Cormier-Daire, V., Rotig, A., Munnich, A., Rustin, P. and Shoubridge, E.A. (2001) Mutations in SURF1 are not specifically associated with Leigh syndrome. J. Med. Genet., 38, 109-113.